Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients

OBJECTIVES: In addition to motor symptoms, bladder dysfunction is a major clinical issue in patients with Parkinson disease (PD). Istradefylline is adenosine A2A receptor antagonist approved for PD patients with wearing-off symptoms. The aim of this study was to determine the long-term effects of is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Neuropharmacol
Main Authors: Kitta, Takeya, Yabe, Ichiro, Kanno, Yukiko, Higuchi, Madoka, Ouchi, Mifuka, Togo, Mio, Moriya, Kimihiko, Takahashi, Ikuko, Matsushima, Masaaki, Sasaki, Hidenao, Shinohara, Nobuo
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5965927/
https://ncbi.nlm.nih.gov/pubmed/29672326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WNF.0000000000000281
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados